patients

MannKind If approved, ReadyFlow Autoinjector would deliver an IV-equivalent diuretic dose (subcutaneous furosemide injection 80 mg/ml) in under…

The NICE threshold will rise to £25,000 to £35,000 for every quality adjusted life year. In return for…

Luca Goodwin, 11, was born with a congenital heart defect and had to undergo three rounds of open-heart…

A group of doctors has warned the government that the move could erode patient trust. While the direction…

One-in-10 mental health patients in South Australian hospital emergency departments are waiting “more than 35 hours” for a…

YELLOWSTONE COUNTY — A 20-year partnership between oncologists at the Yellowstone Naturopathic Clinic and Intermountain Health has come…

Professor George Hanna, head of the Department of Surgery and Cancer at Imperial College London – who is…

Britain’s auto industry also only exports a small amount of Heavy Goods Vehicles to the U.S., but “we’re…

Eli Lilly and Novo Nordisk are vying for supremacy in the weight-loss market they dominate as they both…

The stock takes put pressure on departments to get their ducks in a row, said people with knowledge…

MannKind Announces U.S. FDA Accepts for Review its Supplemental New Drug Application (sNDA) of FUROSCIX ReadyFlow™ Autoinjector for the Treatment of Edema in Adults with Chronic Heart Failure or Chronic Kidney Disease